Hyderabad Telangana, India

Bala Mallikarjunarao Garlapati

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Tata Consultancy Services Limited. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bala Mallikarjunarao Garlapati. Retrieved from https://idiyas.com/inventor/bala-mallikarjunarao-garlapati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Bala Mallikarjunarao Garlapati

Introduction: Bala Mallikarjunarao Garlapati is a renowned inventor based in Hyderabad, India, known for his groundbreaking innovations in various fields.

Latest Patents: Bala Mallikarjunarao Garlapati holds several patents in the areas of renewable energy, sustainable agriculture, and healthcare technologies.

Career Highlights: With a career spanning over two decades, Bala Mallikarjunarao Garlapati has worked with leading research institutions and universities to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Bala Mallikarjunarao Garlapati has collaborated with multinational companies, startups, and government agencies to bring his inventions to the market and make a difference in the world.

Conclusion: Bala Mallikarjunarao Garlapati's dedication to innovation and his passion for creating solutions to global challenges have established him as a prominent figure in the field of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…